Past Event
Date
Sept 27 - Oct 1, 2024
Location
Philadelphia, PA
The Effect of Modulating Alpha-synuclein Aggregation on Clinical Outcome in the Presence of Standard-of-care Dopaminergic Therapy in Parkinson’s Disease. A Quantitative Systems Pharmacology Approach
Presenter: Hugo Geerts, PhD, Head QSP Neurosciences, Certara